Please provide your email address to receive an email when new articles are posted on . Over the past several months, two new agents have become available to aid clinicians in preventing infections ...
REHOVOT, Israel and HOBOKEN, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for ...
ROSWELL, Ga., Jan. 14, 2019 /PRNewswire-PRWeb/ -- The Centers for Disease Control (CDC) has updated information related to the use and availability of VARIZIG® (Varicella Zoster Immune Globulin [Human ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Varicella zoster immune globulin (VZIG) has been the mainstay of therapy for postexposure prophylaxis of varicella for patients at high risk for severe disease and complications. However, the U.S.
(RTTNews) - Kamada Ltd. (KMDA), a biopharmaceutical company specializing in rare and serious conditions, announced on Monday that it has been awarded a three-year contract with an international ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results